EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Stereoselective Determination of Omeprazole and 5‐Hydroxy‐Omeprazole in Dried Blood Spots for CYP2C19 Activity Assessment

Toon Hectors iD, Kenza Abouir iD, Emmanuel Varesio iD, Martijn L Manson iD, Youssef Daali iD, Caroline Samer iD

Basic & Clinical Pharmacology & Toxicology · 2026

DOI: 10.1111/bcpt.70326 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Basic & Clinical Pharmacology & Toxicology, 2026. Verfasst von Toon Hectors und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Systems Pharmacology and Pharmacy, Leiden Academic Centre for Drug Research, Leiden, Netherlands. Hauptthemen laut MEDLINE: Omeprazole, Cytochrome P-450 CYP2C19, Cytochrome P-450 CYP2C19 Inhibitors, Proton Pump Inhibitors. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We previously proposed stereoselective 5‐hydroxy‐omeprazole/omeprazole cut‐offs for R‐ and S‐omeprazole to differentiate between rapid, normal, and poor CYP2C19 metabolisers. However, the performance of these stereoselective CYP2C19 phenotyping approaches has never been compared with conventional racemic omeprazole phenotyping. Therefore, dried blood spots from healthy, genetically predicted rapid ( n = 15), normal ( n = 15), and intermediate ( n = 14) CYP2C19 metabolisers were stereoselectively reanalysed after administration of omeprazole alone (10 mg) and following CYP2C19 inhibition with voriconazole (400 mg administered prior to omeprazole). Using stereoselective R‐, S‐, and racemic 5‐hydroxy‐omeprazole/omeprazole ratios, CYP2C19 phenotyping performance was assessed by genotype–phenotype concordance and phenoconversion patterns relative to prior reports. An adaptive phenotyping strategy using the 3‐h metabolic ratio in individuals with delayed absorption and retaining the 2‐h ratio otherwise improved agreement with AUC‐based CYP2C19 activity measures (Spearman ρ = 0.99 vs. 0.93 and 0.88 for fixed 2‐ and 3‐h ratios, respectively). Across methods, the racemic approach demonstrated the most favourable overall performance, closely followed by the S‐enantiomer–based strategy. In conclusion, while racemic omeprazole phenotyping modestly remains the most accurate strategy for assessing CYP2C19 activity, stereoselective assessment of the S‐enantiomer provides an alternative that enables CYP2C19 phenotyping in patients treated with esomeprazole without treatment interruption or substitution with omeprazole.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OmeprazoleCytochrome P-450 CYP2C19Cytochrome P-450 CYP2C19 InhibitorsProton Pump InhibitorsHumansStereoisomerismPhenotypeGenotypeVoriconazoleArea Under Curve2-Pyridinylmethylsulfinylbenzimidazoles

Stichwörter der Autor:innen

CYPdrug–drug interactionsmetabolismpharmacogeneticsphenotype

Substanzen

OmeprazoleCytochrome P-450 CYP2C19CYP2C19 protein, human5-hydroxymethylomeprazoleCytochrome P-450 CYP2C19 InhibitorsVoriconazoleProton Pump Inhibitors2-Pyridinylmethylsulfinylbenzimidazoles

Autor:innen und Institutionen

  • Division of Systems Pharmacology and Pharmacy, Leiden Academic Centre for Drug Research, Leiden, Netherlands.
  • Department of Clinical Pharmacy and Toxicology, Leiden University Medical Centre, Leiden, Netherlands.
  • Division of Clinical Pharmacology and Toxicology, Department of Acute Care Medicine, Geneva University Hospitals, Geneva, Switzerland.
  • Department of Anaesthesiology, Pharmacology, Intensive Care and Emergency Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
  • School of Pharmaceutical Sciences, Faculty of Sciences, University of Geneva, Geneva, Switzerland.

ORCID-Profile: Toon Hectors, Kenza Abouir, Emmanuel Varesio, Martijn L Manson, Youssef Daali, Caroline Samer

Zitieren

APA

Hectors, T., Abouir, K., Varesio, E., Manson, M. L., Daali, Y., & Samer, C. (2026). Stereoselective Determination of Omeprazole and 5‐Hydroxy‐Omeprazole in Dried Blood Spots for CYP2C19 Activity Assessment. Basic & Clinical Pharmacology & Toxicology. https://doi.org/10.1111/bcpt.70326

Vancouver

Hectors T, Abouir K, Varesio E, Manson ML, Daali Y, Samer C. Stereoselective Determination of Omeprazole and 5‐Hydroxy‐Omeprazole in Dried Blood Spots for CYP2C19 Activity Assessment. Basic & Clinical Pharmacology & Toxicology. 2026. doi:10.1111/bcpt.70326

BibTeX
@article{Hectors2026,
  author = {Hectors, Toon and Abouir, Kenza and Varesio, Emmanuel and Manson, Martijn L and Daali, Youssef and Samer, Caroline},
  title = {Stereoselective Determination of Omeprazole and 5‐Hydroxy‐Omeprazole in Dried Blood Spots for CYP2C19 Activity Assessment},
  journal = {Basic & Clinical Pharmacology & Toxicology},
  year = {2026},
  doi = {10.1111/bcpt.70326}
}
Kostenlos starten →